Van Der Doelen MJ, Kuppen MCP, Jonker MA, et al. Real world lessons for optimal selection of patients with bone metastatic castration-resistant prostate cancer for radium-223 therapy. EMUC 2017, P049.
Datopotamab deruxtecan bij gevorderde HR+/HER2- en tripelnegatieve borstkanker
jun 2024 | Borstkanker